Precision Preclinical Models for Autoimmune & Inflammatory Drug Discovery

Inflammation & Immune Disease Models
Provide highly predictive, human-relevant insights that accelerate therapeutic discovery and reduce clinical trial risks.

Our Immunology & Inflammation Models

Inflammation and immune-related diseases arise from dysregulated immune responses, leading to conditions such as autoimmune disorders, chronic inflammation, and fibrosis. Understanding these complex conditions requires highly predictive preclinical models that accurately replicate human disease mechanisms.

Medicilon’s validated in vivo models offer clinically relevant insights, enabling researchers to decipher disease pathways to identify novel therapeutic targets, evaluate drug efficacy and immune modulation with precision, and assess disease progression to optimize treatment strategies. With a focus on accelerating therapeutic advancements, our models support the development of next-generation immunotherapies, biologics, and targeted treatments.

Clinically Predictive & Translational

Our models accurately mimic human immune system dysregulation, ensuring high translational relevance.

Customizable Study Designs

We tailor study parameters to your specific research needs, allowing for precise mechanistic and efficacy evaluations.

Supports Diverse Therapeutic Modalities

Ideal for biologics, immune modulators, targeted therapies, and small molecules.

Accelerated Preclinical Drug Development

Our efficient, reproducible models enable rapid and reliable preclinical insights, de-risking clinical progression.

Models for Inflammatory & Immune Diseases

 

Medicilon offer a diseases models for inflammatory and immune diseases, allowing researchers to accelerate therapeutic discovery and reduce clinical trial risks.

 

Our Available Syngeneic Mouse:

Animal Model
Disease
Diease Type
Animal Type

Partner with Medicilon for Preclinical Inflammation Studies

At Medicilon, we go beyond providing models, we collaborate with researchers to refine therapeutic strategies, accelerate drug discovery timelines, and enhance the success of immunotherapies.

 

Our state-of-the-art facilities and expert immunology team deliver high-quality, impactful data to support your drug development pipeline.

How Orthotopic Models Power Cancer Research

Key Models highlights
  • Testing Drug Efficacy in a Natural Tumor Environment: Get accurate data on tumor growth inhibition, drug penetration, and therapeutic impact.
  • Metastasis Research: Study how cancer spreads, test anti-metastatic therapies, and track tumor dissemination in real-time.
  • Combination Therapy Development: Evaluate the effectiveness of multi-drug regimens and optimize treatment strategies.
  • Immune System & Tumor Microenvironment Studies: Explore how tumors interact with immune cells, aiding in the development of immunotherapies.

Tumor

Head & Neck Cancer
Nasopharyngeal Carcinoma Stem Cells
Lung Cancer
Breast Cancer
Gastric Cancer
Pancreatic Cancer
Kidney Cancer
Liver Cancer
Glioblastoma
Fibroma
Colon & Appendix Cancer
Leukemia

Neurological disease

Depression Model
Convulsive Model
Sedative-Hypnotic-anxiolytic Model
Parkinson’s Disease Model
Dementia Model
Schizophrenia Model

Digestive system disease

Gastric Acid Secretion Model
Gastric Ulcer Model
Ulcerative Colitis
Gastrointestinal Dynamics Model

Metabolic disease

Obesity and Diabetes Model
Hyperuricemia Model
Liver Fibrosis Model
Pulmonary Fibrosis Model
Dyslipidemia Model
Non-Alcoholic Fatty Liver Model
Hepatobiliary Model

Cardiovascular diseases

Thrombosis, Anticoagulation Model
Stroke Model
Atherosclerosis Model
Anemia Model

Inflammatory & immune disease

Arthritis and Osteoarthritis Model
Osteoporosis Model
Psoriasis Model
Atopic Dermatitis Model
Multiple Sclerosis Model
Acute Inflammation Model

Other disease models

Skin Trauma Model
Kidney Failure & Kidney Injury model
Gynecological Disease Model

Let’s Drive Immuno-Oncology Innovation - Together

At Medicilon, we don’t just offer models – we provide end-to-end support for your oncology research. Our team of highly experienced scientists and cutting-edge facilities ensure:

  • Fast, high-quality study execution to keep your research moving forward.

 

  • Data-driven insights for more informed decision-making.

 

  • Customized research solutions tailored to your specific drug development needs.
Tumor Models
Xenograft Models (186+)
Humanized Models (30+)
Syngeneic Models (30+)
Orthotopic Models (50+)
PDX Models (100+)
Non-tumor Models
CNS Diseases Models (64+)
Inflammatory & Immune Diseases (32+)
Cardiovascular Diseases (25+)
Metabolic Diseases (39+)
Digestive Diseases Models (18+)
cancer therapy INNOVATION

Integration Across Oncology Models

Medicilon provides a full suite of preclinical models, ensuring a smooth transition between different research phase.

Tumor models:

Medicilon provides a comprehensive range of oncology models, including:

  • CDX Models – Rapid, cost-effective screening for early-phase drug development.
  • PDX Models – Clinically relevant, patient-matched models for personalized therapy research.
  • Orthotopic Models – Study tumor progression in its native environment for improved therapeutic evaluation.
  • Humanized Mouse Models – Bridge the gap between preclinical and clinical immunotherapy studies.
 

By leveraging syngeneic models alongside other in vivo platforms, researchers can refine drug candidate selection, reduce clinical trial failure rates, and accelerate the path to breakthrough therapies.

 

Refine therapeutic strategies, and enhance the success of immunotherapies

Contact Medicilon

Name(Required)
Address

Search Medicilon

Medicilon DMPK & Bioanalysis Services (Download)

Medicilon—High Quality Integrated Drug R&D Services (Download)

Medicilon Large Animal Pharmacodynamic Research Service Platform (Download)